Liver stiffness and serum galectin 3 level significantly increases in patients with prediabetes: a fibroscan study
Aim Diabetes mellitus (DM) is associated with the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). In our study, we aimed to evaluate the relationship between liver stiffness (LS) and galectin-3 levels in patients diagnosed with prediabetes. Methods A...
Saved in:
| Main Authors: | Huseyin Ali Ozturk, Hilmi Erdem Sumbul |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2025-04-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/19377.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus
by: Hilmi Erdem Sümbül, et al.
Published: (2025-03-01) -
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes
by: Stefano Ciardullo, et al.
Published: (2025-06-01) -
Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE Thresholds and Diagnostic Accuracies for Detecting Hepatic Fibrosis in Patients with MASLD: A Systematic Review and Meta-Analysis
by: Mitchell Patrick Wilson, et al.
Published: (2025-06-01) -
Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Children with Overweight and Obesity by Transient Elastography
by: Mohamed Fajrudheen, et al.
Published: (2025-03-01) -
Significant Within-Individual Variability in VCTE Liver Stiffness Measurements at Two Intercostal Spaces in Subjects with MASLD: Implications for Evaluating Improvement in Liver Fibrosis After Weight-Loss or Liver-Directed Therapy
by: Jordan S. Woodard, et al.
Published: (2024-11-01)